People
U.S. federal lawmakers are discussing various legislative plans that could lower the out-of-pocket expenses many Americans pay for their medications. The plans are coming from both chambers of Congress and with a divided government, lines in the sand will likely be drawn.
On Jan. 11, President Donald Trump announced via Twitter that 2018 was marked by a decline in prescription drug prices – the first time that had happened in 50 years. Also, the president said that Americans saved $26 billion on drug prices in the first 19 months of his presidency.
Noting that the U.S. Food and Drug Administration (FDA) expects more than 200 investigational new drug applications (INDs) by 2020 per year, many of them cell and gene therapies, the agency issued an outline of new procedures it plans to implement this year.
Fridtjof Helemann will leave the company on 31 March 2019, upon reaching retirement age.
Developing treatments to help those struggling with depression, a disorder that can lead to suicide, has become a mission for Shawn Singh, CEO of VistaGen, and his colleagues.
In a reflection on the annual healthcare conference, VC Bruce Booth criticizes the high cost of attending JPM, as well as the focus on market share instead of patients.
Pharnext SA announced the appointment of Susanne Dorn, M.Sc., as Chief Regulatory Officer and Serge Fitoussi, M.D., M.Sc., as Chief Medical Officer
Auditdata announces that founder and CEO of Auditdata will step down and incoming CEO Kurt Bager will take over at the end of January 2019
New Year, fresh start? Could be. WalletHub recently compared more than 180 cities across the U.S., using 30 key indicators to evaluate their job strength. Some of those factors were job opportunities, employment growth, monthly average starting salary and employment outlook.
After four years at AstraZeneca, Chief Medical Officer Sean Bohen will be leaving the company following an organizational shakeup at the U.K.-based pharma giant. Bohen joined AstraZeneca from Genentech in 2015 and also serves as head of global medicines development.
PRESS RELEASES